Clinical Case Studies in Venous Thromboembolism: Using Direct Oral Anticoagulants for Treatment and Secondary Prevention
After registration you will receive an email confirmation with instructions for joining the webinar.
Available at least 24 hours before webinar.
Activity Type: Application-based
CE Credits: 1.0 (0.1 CEU), no partial credit for pharmacists
Activity Fee: Free of charge
Accreditation for Pharmacists
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Accreditation for Physicians
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The American Society of Health-System Pharmacists designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Target Audience
This continuing education activity was planned to meet the needs of clinicians with an interest in venous thromboembolism (VTE), especially primary care providers, emergency room physicians, hospitalists, cardiologists, pulmonologists, vascular surgeons, hematologists, and pharmacists in hospitals and ambulatory care clinics who care for patients with VTE.
Activity Overview
Clinical case studies will be used to illustrate the decision-making process regarding the acute treatment and secondary prevention of venous thromboembolism (VTE) based on recently updated guidelines and clinical trial data. Strategies for overcoming barriers to the appropriate use of direct oral anticoagulants and for ensuring long-term follow-up also will be discussed.
Learning Objectives
After the conclusion of this application-based educational activity, participants should be able to- Incorporate direct oral anticoagulants (DOACs) into existing venous thromboembolism (VTE) pathways, including strategies for ensuring appropriate long-term follow-up.
- Develop a plan for overcoming barriers to the appropriate use of DOACs for the acute treatment and secondary prevention of VTE.
Faculty
Alpesh Amin, M.D., MBA, FACC, MACP, SFHM
Thomas & Mary Cesario Chair of Medicine
Professor of Medicine, Business, Public Health, Nursing Science, and Biomedical Engineering
Executive Director, Hospitalist Program
Medical Director, Anticoagulation Services
University of California, Irvine
Irvine, California
Alpesh Amin, M.D., MBA, FACC, MACP, SFHM, is the Thomas & Mary Cesario Chair of the Department of Medicine at the University of California, Irvine (UCI). He is Professor of Medicine, Business, Public Health, Nursing Science, and Biomedical Engineering at UCI. He is also founder and executive director of the Hospitalist Program. At UCI, Dr. Amin has served as Vice Chair for Clinical Affairs and Quality, Chief of the Division of General Internal Medicine (GIM), Associate Program Director of the Internal Medicine Residency Program, and Medicine Clerkship Director. Dr. Amin obtained his Doctor of Medicine degree at Northwestern University Medical School in Chicago, and he completed his internship and residencies in internal medicine, including a chief residency, at UCI. He also earned a healthcare MBA degree at UCI. Dr. Amin is the first hospitalist to be named chief of a division of GIM, and then subsequently the first hospitalist to be named chair of a department of medicine nationally.
Throughout his career, Dr. Amin has been innovative in clinical, quality, and educational program development. He has advised the Hamad Medical Corporation (HMC) in Doha, Qatar on quality improvement efforts across eight hospitals under the national health ministry council. He has developed processes to improve patient care delivery looking at ways to reduce readmission and avoidable admissions, decrease length of stay and mortality, and improve customer service. Dr. Amin is an expert in implementation science and measuring outcomes to improve sustainable results. He has also applied information technology to improve the delivery of care through development of projects such as NHCPlus, eConsults, and Apps for Safe Anticoagulation Use.
During the course of his career, Dr. Amin has served as principal investigator, co-investigator, and faculty sponsor on clinical trials and research projects focusing on clinical topics, such as venous thromboembolism, pneumonia, and heart failure. His research interest is in health outcomes related to patient safety, quality improvement, and medical education. He is a member of Society of Hospital Medicine (SHM), American College of Physicians (ACP), Society of General Internal Medicine, Academic Chiefs and Leaders of General Internal Medicine (ACLGIM), Academic Alliance of Internal Medicine, and Association of Professors of Medicine. Within SHM, he has served as the Annual Meeting Course Director and on the Board of Directors. Dr. Amin has authored or co-authored over 170 peer-reviewed articles. He is the co-editor and co-author of Core Competencies for Hospital Medicine by SHM. Dr. Amin is also co-editor of the book, Contemporary Hospitalist Guide to Anticoagulation.
Dr. Amin has been honored by being named a Master of ACP, Senior Fellow of SHM, and Fellow of American College of Cardiology. He also has been awarded the ACP Special Recognition Award, ACP Top 10 Hospitalist Award, Orange County Physician of Excellence Award, and he was named one of “America’s Top Physicians” by the Consumers’ Research Council of America. In addition, he received the Alfred Soffer Award from ACCP, Venous Research Award for Quality Improvement and Implementation of Best Practices from the Venous Disease Coalition (VDC)/Vascular Disease Foundation (VDF), Exceptional Leadership Award from ACLGIM, CDC Healthcare-associated VTE Prevention Champion, and HMC Star of Excellence Award. He founded and directs the UCI Anticoagulation Clinic, which is recognized nationally as an AC Forum Center of Excellence.
John Fanikos, R.Ph., MBA
Executive Director of Pharmacy Services
Brigham and Women’s Hospital
Adjunct Professor of Clinical Pharmacy
Massachusetts College of Pharmacy and Health Sciences
Boston, Massachusetts
John Fanikos, R.Ph., M.B.A., is Chief of Pharmacy Services at Brigham and Women's Hospital (BWH) in Boston, Massachusetts. Mr. Fanikos is responsible for the overall Pharmacy Department operations. As part of his research interests, he has worked closely with the BWH Thromboembolism Research Group for over 25 years. He has authored and co-authored over 100 peer reviewed articles and textbook chapters on medication use with a specific emphasis on optimizing medication utilization. His research focus has been identifying and avoiding the problems and pitfalls of medication use.
Relevant Financial Relationship Disclosure with an Ineligible Company*
- Consultant, Pfizer
- Consultant, Pacira
- Consultant, Boehringer-Ingelheim
- Consultant, Allergan
- Consultant, Alexion
All of the relevant financial relationships have been mitigated.
*As defined by the Standards of Integrity and Independence definition of ineligible company.
Methods and CE Requirements
This is a live broadcast consisting of audio, presentation slides, and an activity evaluation tool. A live webinar brings the presentation to you. Listen to the speaker present in “real time” as you watch the slides on the screen. You will have the opportunity to ask the speaker questions at the end of the program. Please join the conference at least 5 minutes before the scheduled start time for important announcements.
To receive CE credit, participants must submit an enrollment code (announced during the webinar) and complete the evaluation. Participants will process CE credit online at http://elearning.ashp.org/my-activities. CPE credit will be reported directly to CPE Monitor. Per ACPE, CPE credit must be claimed no later than 60 days from the date of the live activity or completion of a home-study activity.
Viewing Webinar as a Group
To view the webinar as a group, one person serving as the group coordinator should register. A few minutes before the webinar begins, the group coordinator should launch the webinar (using instructions from the email confirmation) and select the option to open audio via VoIP (Voice Over IP) or use a touch tone phone with the dial-in information. Each participant will process their own continuing education online.
Webinar System Requirements
Be sure to view the webinar system requirements for Windows, Mac, iOS, and Android prior to the activity.
